PubMed:12057899 / 925-1183
Annnotations
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T184 | 8-26 | D015179 | denotes | colorectal cancers |
T185 | 8-26 | D015179 | denotes | colorectal cancers |
T188 | 92-95 | Q63276 | denotes | BAT |
T189 | 92-95 | PR:000004614 | denotes | BAT |
T191 | 92-95 | Q14032 | denotes | BAT |
T192 | 92-95 | Q91X34 | denotes | BAT |
T190 | 92-95 | UBERON:0001348 | denotes | BAT |
T193 | 112-118 | D009369 | denotes | tumors |
T194 | 112-118 | D009369 | denotes | tumors |
T195 | 121-129 | PR:000000046 | denotes | TGF beta |
T196 | 121-129 | D016212 | denotes | TGF beta |
T197 | 121-129 | D016212 | denotes | TGF beta |
T200 | 141-153 | CHEBI:47885 | denotes | dinucleotide |
T202 | 169-172 | CHEBI:16768 | denotes | MSH |
T206 | 169-172 | D009074 | denotes | MSH |
T207 | 169-172 | D009074 | denotes | MSH |
T208 | 169-173 | PR:O65607 | denotes | MSH3 |
T209 | 169-173 | PR:000010667 | denotes | MSH3 |
T210 | 169-173 | PR:Q59Y41 | denotes | MSH3 |
T211 | 169-173 | PR:P25336 | denotes | MSH3 |
T212 | 169-173 | PR:P20585 | denotes | MSH3 |
T213 | 169-173 | PR:P26359 | denotes | MSH3 |
T214 | 169-173 | PR:P13705 | denotes | MSH3 |
T215 | 169-173 | PR:Q1ZXH0 | denotes | MSH3 |
T217 | 185-188 | PR:000035019 | denotes | BAX |
T218 | 185-188 | PR:Q07813 | denotes | BAX |
T219 | 185-188 | PR:P27297 | denotes | BAX |
T220 | 185-188 | PR:Q07812 | denotes | BAX |
T221 | 185-188 | PR:Q63690 | denotes | BAX |
T222 | 185-188 | PR:000002193 | denotes | BAX |
T216 | 185-188 | CVCL_N585 | denotes | BAX |
T223 | 238-257 | D016889 | denotes | endometrial cancers |
T224 | 238-257 | D016889 | denotes | endometrial cancers |
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 19-26 | HP_0002664 | denotes | cancers |
T7 | 112-118 | HP_0002664 | denotes | tumors |
T8 | 250-257 | HP_0002664 | denotes | cancers |
UseCases_ArguminSci_Discourse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 0-258 | DRI_Outcome | denotes | Whereas colorectal cancers displayed a predominant pattern consisting of instability at the BAT loci (in 89% of tumors), TGF beta RII (73%), dinucleotide repeats (70%), MSH3 (43%), and BAX (30%), no such single pattern was discernible in endometrial cancers. |
DisGeNET5_gene_disease
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
12057899-4#169#173#gene4437 | 169-173 | gene4437 | denotes | MSH3 |
12057899-4#185#188#gene581 | 185-188 | gene581 | denotes | BAX |
12057899-4#238#257#diseaseC0476089 | 238-257 | diseaseC0476089 | denotes | endometrial cancers |
169#173#gene4437238#257#diseaseC0476089 | 12057899-4#169#173#gene4437 | 12057899-4#238#257#diseaseC0476089 | associated_with | MSH3,endometrial cancers |
185#188#gene581238#257#diseaseC0476089 | 12057899-4#185#188#gene581 | 12057899-4#238#257#diseaseC0476089 | associated_with | BAX,endometrial cancers |
DisGeNET
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 185-188 | gene:581 | denotes | BAX |
T7 | 238-257 | disease:C0476089 | denotes | endometrial cancers |
T8 | 169-173 | gene:4437 | denotes | MSH3 |
T9 | 238-257 | disease:C0476089 | denotes | endometrial cancers |
T10 | 92-95 | gene:570 | denotes | BAT |
T11 | 8-26 | disease:C1527249 | denotes | colorectal cancers |
T12 | 92-95 | gene:570 | denotes | BAT |
T13 | 238-257 | disease:C0476089 | denotes | endometrial cancers |
R4 | T6 | T7 | associated_with | BAX,endometrial cancers |
R5 | T8 | T9 | associated_with | MSH3,endometrial cancers |
R6 | T10 | T11 | associated_with | BAT,colorectal cancers |
R7 | T12 | T13 | associated_with | BAT,endometrial cancers |